inVentive Health Logo    Print Page | Close Window

Overview

Coherus is a late-stage biologics platform company focused on the global biosimilar market. Headquartered in the San Francisco Bay Area and composed of a team of industry veterans with decades of experience in pioneering biologics companies, our goal is to become a global leader in the biosimilar market by leveraging our team’s collective expertise in key areas such as process science, analytical characterization, protein production and clinical-regulatory development. Our commercialization partnerships include global pharmaceutical companies in Europe, Asia and Latin America.

Recent News

DateTitle
12/01/17Coherus BioSciences Management to Present at BMO’s Prescriptions for Success Healthcare Conference
REDWOOD CITY, Calif., Dec. 01, 2017 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq:CHRS) today announced that senior management will be participating in a fireside chat at the BMO Prescriptions for Success Healthcare Conference on Thursday, December 14, 2017 at 1:30 p.m. EST being held in New York, NY. The audio portion of the presentations will be available on the investors page of the Coherus BioSciences website at http://investors.coherus.com. About Coherus BioSciences, Inc. Coh... 
11/06/17Coherus BioSciences Reports Third Quarter 2017 Operating and Financial Results
REDWOOD CITY, Calif., Nov. 06, 2017 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq:CHRS), today reported financial results and reviewed corporate events for the third quarter ended September 30, 2017. Corporate Highlights for the Third Quarter 2017 Include: Immunology (anti-TNF) therapeutic franchise: CHS-0214 (etanercept (Enbrel®) biosimilar candidate)    -  Filed petitions for Inter Partes Review (“IPR”) in the United States Patent and Trademark Office seeking invalidation o... 
11/01/17Coherus BioSciences Management to Present at Credit Suisse Scottsdale Healthcare Conference
REDWOOD CITY, Calif., Nov. 01, 2017 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq:CHRS) today announced that senior management will be participating in a fireside chat at the Credit Suisse Scottsdale Healthcare Conference on Tuesday, November 7, 2017 at 4:45pm ET being held in Scottsdale, AZ. The audio portion of the presentations will be available on the investors page of the Coherus BioSciences website at http://investors.coherus.com. About Coherus BioSciences, Inc. Coherus is a... 
10/23/17Coherus BioSciences to Report Third Quarter 2017 Financial Results on November 6th
REDWOOD CITY, Calif., Oct. 23, 2017 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq:CHRS), today announced that its third quarter 2017 financial results will be released after market close on Monday, November 6th, 2017.  Starting at 4:30 p.m. EDT, Coherus’ management will host a conference call to discuss the financial results and provide a general business update.   After releasing third quarter 2017 financial results, we will post them on the Coherus BioSciences website at http://in... 
View All

Receive E-mail Alerts

Sign up to receive e-mail alerts whenever Coherus Biosciences Inc posts new information to the site. Just enter your e-mail address and click Submit.